Results 281 to 290 of about 167,619 (306)
Some of the next articles are maybe not open access.

New developments in the urokinase-type plasminogen activator system

Expert Opinion on Therapeutic Targets, 2001
The urokinase-type plasminogen activator (uPA) system plays a central role in control of cell surface proteolysis and extracellular matrix degradation. Components of this system are upregulated in a wide variety of human cancers and high levels of these proteins predict more rapid relapse and shorter survival.
openaire   +2 more sources

Urokinase-Type Plasminogen Activator and PAI-1

2006
Urokinase plasminogen activator (uPA) is a serine protease causally involved in tumor progression. In vivo, uPA can be inhibited by the serpin inhibitor plasminogen activator inhibitor-1 (PAI-1). However, PAI-1 is a multifunctional protein that can also play a role in cell migration, cell adhesion, angiogenesis, and apoptosis.
openaire   +2 more sources

Breaking the fibrinolytic speed limit with microwheel co‐delivery of tissue plasminogen activator and plasminogen

Journal of Thrombosis and Haemostasis, 2022
Dante Disharoon   +2 more
exaly  

Functions of the plasminogen receptor Plg‐RKT

Journal of Thrombosis and Haemostasis, 2020
Juliana P Vago   +2 more
exaly  

Plasminogen Activator Inhibitor Type‐1 as a Regulator of Fibrosis

Journal of Cellular Biochemistry, 2018
Maryam Boshtam, Rui Dinis, Hamed Mirzaei
exaly  

Plasminogen deficiency

Haemophilia, 2008
Mauro Tognon
exaly  

Home - About - Disclaimer - Privacy